Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients

BACKGROUND: Intravitreal methotrexate has been proven to be an effective treatment method for vitreoretinal lymphoma. However, keratopathy occurs as the major side effect during treatment in most cases. The purpose of this study is to describe the characteristics of primary central nervous system ly...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Ophthalmol
Glavni autori: Zhou, Xian, Zhou, Xianjin, Shi, Huimin, Lai, Jie, Wang, Qingping, Li, Yi, Chen, Kun, Li, Qingjian, Zhou, Qiang, Cao, Xia, Chen, Bobin, Xiao, Jianjiang
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216350/
https://ncbi.nlm.nih.gov/pubmed/32397978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-020-01464-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items